comprehensive -WSS

comprehensive

author：leisure time 2025-09-28 18:47:54 - browse：12

When is a failure not a failure? Does the FDA have special rules for Sarepta Therapeutics? And how do you say “brash” in French?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Biotech consultant Frank David joins us to explain the wild world of subgroup analyses and how to discern science from spin. We also discuss the latest news in the life sciences, including the future of Sarepta and the retirement of a biotech stalwart.

For more on what we cover, here’s where you can read Frank’s work; here’s more on Sarepta; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Heart attack and stroke risk calculators need revising
Next article： Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

focus

entertainment

WSS

A former Republican legislative candidate has been charged for his role in the US Capitol riot

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Washington Commanders' Dan Snyder ordered to pay NFL $60M following investigation

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

Readout LOUD podcast: mifepristone case, GLP

Abortion pill Supreme Court ruling could impact entire drug industry

Wikipedia

comprehensive

focus

Drug repurposing or repositioning? The language matters

A new deal aims to ramp up use of AI in rehab care decisions

Heart attack and stroke risk calculators need revising

Why Marc Tessier

Psychedelics group wrestles with new pharma identity

Roche subsidiary Foundation Medicine opens new headquarters

Sports medicine is finally prioritizing gender equality

Supreme Court mifepristone arguments center on docs' right to sue

In age of alternative facts, a scholarly course on calling out crap

A former Republican legislative candidate has been charged for his role in the US Capitol riot

hotspot

EMA weighs against approval for Mirati's lung cancer drug

Why Marc Tessier

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

Scientists boost immune system in aging mice by making it youthful

It's time to take a new tack for treating Alzheimer's

'The View' co

focus

focus

entertainment

explore